Clinical Trial Update: An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)

View source ↗

Summary

This ClinicalTrials.gov audit reports results from Crohn's disease patients treated with infliximab. The sponsor was Merck Sharp & Dohme LLC (MSD), and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn's Disease | Status: COMPLETED | Results posted: 2012-07-26